Calvin Sternick

Stock Analyst at JP Morgan

(2.10)
# 2,853
Out of 4,886 analysts
19
Total ratings
46.15%
Success rate
7.28%
Average return

Stocks Rated by Calvin Sternick

U.S. Physical Therapy
Mar 19, 2025
Maintains: Overweight
Price Target: $120$110
Current: $78.97
Upside: +39.30%
Centene
Jul 10, 2024
Maintains: Neutral
Price Target: $85$80
Current: $33.02
Upside: +142.28%
PACS Group
May 6, 2024
Initiates: Overweight
Price Target: $27
Current: $13.03
Upside: +107.21%
Universal Health Services
Mar 13, 2024
Maintains: Neutral
Price Target: $144$182
Current: $184.21
Upside: -1.20%
Tenet Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $91$81
Current: $173.58
Upside: -53.34%
Molina Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $367$392
Current: $233.15
Upside: +68.13%